Abstract
This chapter will discuss diagnosis, staging, and management of renal cell carcinoma.
Keywords
References
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (editos). AJCC cancer staging manual, 8th edition. Springer; 2017
Dabestani S, Marconi L, Hofmann F, et al. Local treatments for metastases of renal cell carcinoma: a systematic review. Lancet Oncol. 2014;15(12):e549–61.
Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (editors). AJCC cancer staging manual, 7th edition. Springer; 2010
Kao GD, Malkowicz SB, Whittington R, et al. Locally advanced renal cell carcinoma: low complication rate and efficacy of postnephrectomy planned with CT. Radiology. 1994;193(3):725–30.
Kothari G, Foroudi F, Gill S, Corcoran NM, Siva S. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review. Acta Oncol. 2015;54(2):148–57.
National Comprehensive Cancer Network. Clinical practice guidelines in oncology: kidney cancer. Available at: http://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf. Accessed 3 Aug 2016.
Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012;110(11 Pt B):E737–43.
Siva S, Ellis RJ, Ponsky L, et al. Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma. Future Oncol. 2016;12(5):637–45.
Stein M, Kuten A, Halpern J, et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol. 1992;24(1):41–4.
Tunio MA, Hashmi A, Rafi M. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. Ann Oncol. 2010;21(9):1839–45.
Wersäll PJ, Blomgren H, Pisa P, Lax I, Kälkner K-M, Svedman C. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncol. 2006;45(4):493–7.
Zelefsky MJ, Greco C, Motzer R, et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(5):1744–8.
Acknowledgment
The authors thank Sunanda Pejavar MD and James Rembert MD for their work on the prior edition of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Garcia, M.A., Gottschalk, A.R. (2018). Renal Cell Carcinoma. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-62642-0_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-62641-3
Online ISBN: 978-3-319-62642-0
eBook Packages: MedicineMedicine (R0)